INTROGEN THERAPEUTICS, INC. SERIES A NON-VOTING CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT June 30, 2001 TABLE OF CONTENTSPurchase Agreement • July 12th, 2001 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations • Delaware
RECITALSRegistration Rights Agreement • July 12th, 2001 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations • Delaware
RECITALSVoting Agreement • July 12th, 2001 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations • Delaware
EXHIBIT 2 AMENDMENT NO. 1 TO JOINT VENTURE AGREEMENT THIS AMENDMENT NO. 1 TO JOINT VENTURE AGREEMENT (this "Amendment") is made and entered into this 28th day of September, 1995 by and among ARMOUR PHARMACEUTICAL COMPANY, a corporation organized under...Joint Venture Agreement • October 11th, 1995 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations
Form of: (CHANGE OF CONTROL) AGREEMENTControl) Agreement • March 31st, 1997 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations • Pennsylvania
EXHIBIT 99.3 AGREEMENT TO FILE JOINTLY We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us. AVENTIS PHARMACEUTICALS INC.Rhone Poulenc Rorer Inc • January 7th, 2002 • Pharmaceutical preparations
Noonan/Russo Communications (212) 696-4455 Anthony J. Russo, Ph.D., ext. 202 Kathryn Metcalfe, ext. 206 RHONE-POULENC RORER AND APPLIED IMMUNE SCIENCES ENTER INTO CASH MERGER AGREEMENT AT $11.75 PER SHARE Santa Clara, CA and Collegeville, PA, USA,...For Immediate Release • November 2nd, 1995 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations
OF THE OTHER PART, IT IS AGREED AS FOLLOWS: ARTICLE I - AMOUNT AND PURPOSE OF LOAN The Bank agrees to grant the Borrower a loan facility (the "Loan") of a maximum amount of USD 200,000,000 (TWO HUNDRED MILLION US DOLLARS) or its equivalent in FRF, DEM...Loan Facility Agreement • November 14th, 1995 • Rhone Poulenc Rorer Inc • Pharmaceutical preparations • London
